Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1036948 | o-Anisaldehyde (3 x 0.5 mL) | 3 x 0,5 ml |
| USP-1037022 | Anisyl Butyrate (5 x 0.5 mL) | 5 x 0,5 ml |
| USP-1037033 | Anisyl Propionate (5 x 0.5 mL) | 5 x 0,5 ml |
| USP-1037044 | Anisyl Phenylacetate (5 x 0.5 mL) | 5 x 0,5 ml |
| USP-1044210 | Astaxanthin Esters from Haematococcus pluvialis (5 x 100 mg) | 5 x 100 mg |
| USP-1046191 | Azelastine Related Compound D (20 mg) (4-(4-chlorobenzyl)phthalazin-1(2H)-one) | 20 mg |
| USP-1050949 | Benzaldehyde Propylene Glycol Acetal (5 x 0.5 mL) | 5 x 0,5 ml |
| USP-1062085 | Benzyl Methyl Sulfide (5 x 0.5 mL) | 5 x 0,5 ml |
| USP-1064122 | N-Benzyl-N-methyl-ethanolamine (3 x 0.2 mL) (2-[benzyl(methyl)amino]ethanol) | 3 x 0,2 ml |
| USP-1082628 | Butyl Heptanoate (5 x 0.5 mL) | 5 x 0,5 ml |
| USP-1084995 | Caffeic Acid (15 mg) | 15 mg |
| USP-1086957 | Calcium Lignosulfonate (40-65) (2 g) | 2 g |
| USP-1090150 | Canola Oil (1 g) | 1 g |
| USP-1096994 | Cefadroxil System Suitability Mixture (25 mg) | 25 mg |
| USP-1097126 | Cefadroxil Related Compound B (25 mg) ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | 25 mg |
| USP-1097148 | Cefadroxil Related Compound D (25 mg) ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | 25 mg |
| USP-1097192 | Cefadroxil Related Compound I (25 mg) ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid) | 25 mg |
| USP-1118361 | Chloroquine Related Compound E (15 mg) (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate) | 15 mg |
| USP-1118394 | Chloroquine Related Compound G (15 mg) (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate) | 15 mg |
| USP-1123135 | Chlorpheniramine Related Compound B (25 mg) (di(pyridin-2-yl)amine) | 25 mg |
| USP-1123146 | Chlorpheniramine Related Compound C (10 mg) (3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine maleate) | 10 mg |
| USP-1179344 | Levomedetomidine - ((R)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride) | 25 mg |
| USP-1206017 | Dimenhydrinate Related Compound E (15 mg) (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione) | 15 mg |
| USP-1223209 | Allyl Disulfide (5 x 0.5 mL) | 5 x 0,5ml |
| USP-1231207 | This item has been discontinued - Ebastine (200 mg) | 200 mg |
| USP-1231229 | This item has been discontinued - Ebastine Related Compound B (100 mg) (1-[4-(Dimethylethyl)phenyl]ethanone) | 100 mg |
| USP-1231230 | This item has been discontinued - Ebastine Related Compound C (15 mg) (4-(diphenylmethoxy)piperidine hydrochloride) | 15 mg |
| USP-1231246 | This item has been discontinued - Ebastine Related Compound D (15 mg) (1-[4-(1,1-Dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one) | 15 mg |
| USP-1231251 | This item has been discontinued - Ebastine Related Compound E (25 mg) (1-[4-(1,1-Dimethylpropyl)phenyl]-4-[4-(diphenylmethoxy)piperidin-1-yl]-butan-1-one fumarate) | 25 mg |
| USP-1231262 | This item has been discontinued - Ebastine Related Compound F (15 mg) (1-[4-(1,1-dimethylethyl)phenyl]-4-[cis-4-(diphenylmethoxy)-1-oxidopiperidin-1-yl]butan-1-one) | 15 mg |
| USP-1231273 | This item has been discontinued - Ebastine Related Compound G (15 mg) (1-[4-(1,1-dimethylethyl)phenyl]-4-[trans-4-(diphenylmethoxy)-1-oxidopiperidin-1-yl]butan-1-one) | 15 mg |
| USP-1231750 | Echinacoside (15 mg) | 15 mg |
| USP-1268863 | This item has been discontinued - Etoricoxib (200 mg) | 200 mg |
| USP-1270435 | Filgrastim (0.98 mg) (COLD SHIPMENT REQUIRED) | 0,98 mg |
| USP-1279054 | Fluorouracil Related Compound E (25 mg) (5-Chloropyrimidine-2,4(1H,3H)-dione) | 25 mg |
| USP-1303750 | Hemoglobin Protease Substrate (100 g) (COLD SHIPMENT REQUIRED) | 100 g |
| USP-1311714 | rHuman Interleukin 4 (51 micrograms) (recombinant interleukin 4, human) (COLD SHIPMENT REQUIRED) | 51 |
| USP-1356599 | Krill Oil (2 g) | 2 g |
| USP-1372061 | Lysophosphatidylcholine (Soy) (40 mg) (COLD SHIPMENT REQUIRED) | 40 mg |
| USP-1372333 | Polyallylamine Hydrochloride (200 mg) (2-propen-1-amine hydrochloride, homopolymer) | 200 mg |
| USP-1375513 | This item has been discontinued - Mebendazole Polymorph C (200 mg) | 200 mg |
| USP-1375524 | Mebendazole Related Compound D (15 mg) (Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate) | 15 mg |
| USP-1396149 | Metaxalone (200 mg) | 200 mg |
| USP-1396150 | Metaxalone Related Compound A (10 mg) (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one) | 10 mg |
| USP-1440819 | Metoclopramide Related Compound A (15 mg) (4-acetamido-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide) | 15 mg |
| USP-1440820 | Metoclopramide Related Compound B (15 mg) (methyl 4-acetamido-5-chloro-2-methoxybenzoate) | 15 mg |
| USP-1440841 | Metoclopramide Related Compound D (15 mg) (methyl 4-acetamido-2-methoxybenzoate) | 15 mg |
| USP-1445620 | Moexipril Related Compound C (20 mg) ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate) | 20 mg |
| USP-1448559 | Moxidectin (200 mg) | 200 mg |
| USP-1448639 | Moxifloxacin Related Compound C (25 mg) (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) | 25 mg |
| USP-1448655 | Moxifloxacin Related Compound E (25 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride) | 25 mg |
| USP-1478083 | R-Ofloxacin (25 mg) ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | 25 mg |
| USP-1478742 | This item has been discontinued - Ormeloxifene Hydrochloride (200 mg) | 200 mg |
| USP-1483017 | Oxazepam Related Compound A (15 mg) (7-chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione) | 15 mg |
| USP-1483039 | Oxazepam Related Compound C (15 mg) (6-chloro-4-phenylquinazoline-2-carbaldehyde) | 15 mg |
| USP-1510051 | Pepsin for Assay (5 x 1 g) (COLD SHIPMENT REQUIRED) | 5 x 1 g |
| USP-1511021 | Perphenazine Related Compound B (15 mg) (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol) | 15 mg |
| USP-1535755 | Phosphatidylcholine (Soy) (50 mg) (COLD SHIPMENT REQUIRED) | 50 mg |
| USP-1535766 | Phosphatidylethanolamine (Soy) (50 mg) (COLD SHIPMENT REQUIRED) | 50 mg |
| USP-1535813 | Scaffold Human Dermis Reference Photomicrographs (CD) | CD |
| USP-1535824 | Bovine Acellular Dermal Matrix Reference Photomicrographs (CD) | CD |
| USP-1541529 | Piperacillin Related Compound E (25 mg) (1-ethylpiperazine-2,3-dione) | 25 mg |
| USP-1568028 | Proguanil Related Compound A (25 mg) (1-cyano-3-isopropylguanidine) | 25 mg |
| USP-1568073 | Proguanil Related Compound E (25 mg) (1-(4-chlorophenyl)-3-cyanoguanidine) | 25 mg |
| USP-1568084 | Proguanil Related Compound F (25 mg) (1-(3,4-dichlorophenyl)-5-isopropylbiguanide hydrochloride) | 25 mg |
| USP-1568095 | Proguanil Related Compound G (25 mg) (1-(3-chlorophenyl)-5-isopropylbiguanide hydrochloride) | 25 mg |
| USP-1598031 | Rabeprazole Related Compound B (15 mg) (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide) | 15 mg |
| USP-1598075 | Rabeprazole Related Compound F (15 mg) (2-{[(4-Chloro-3-methyl-2-pyridyl)methyl]sulfinyl}benzimidazole) | 15 mg |
| USP-1605680 | Powdered Rosemary Hydrophilic Extract (1 g) | 1 g |
| USP-1605952 | Rosmarinic Acid (25 mg) | 25 mg |
| USP-1607200 | Safflower Oil (1 g) | 1 g |
| USP-1611944 | Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride) | 15 mg |
| USP-1617500 | Soybean Oil (1 g) | 1 g |
| USP-1623386 | Compressible Sugar (200 mg) | 200 mg |
| USP-1642347 | Sunflower Oil (1 g) | 1 g |
| USP-1643678 | Tenofovir Disoproxil Related Compound G (15 mg) (O-(Isopropoxycarbonyloxymethyl)-O-isopropyl-{(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]}methylphosphonate) fumarate) | 15 mg |
| USP-1672268 | Topotecan Related Compound A (25 mg) ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 25 mg |
| USP-1672698 | Trandolapril Related Compound A (25 mg) ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester) | 25 mg |
| USP-1673533 | Trazodone Related Compound C (20 mg) (2-{3-[4-(4-chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride) | 20 mg |
| USP-1673566 | Trazodone Related Compound F (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride) | 25 mg |
| USP-1681800 | Triclocarban (200 mg) | 200 mg |
| USP-1681856 | Triclocarban Related Compound D Mixture (15 mg) (Mixture of 3,5-Bis(4-chlorophenyl)-1-(3,4-dichlorophenyl)biuret and 1,5-Bis(4-chlorophenyl)-3-(3,4-dichlorophenyl)biuret) | 15 mg |
| USP-1707817 | D-Valacyclovir (25 mg) (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester) | 25 mg |
| USP-1724066 | Zanamivir Resolution Mixture (0.25 mg) (Mixture of zanamivir and talo-zanamivir) | 0,25 mg |
| USP-1724077 | Zanamivir Related Compounds Mixture (2.5 mg) | 2,5 mg |
| USP-1724088 | Zanamivir (200 mg) | 200 mg |
| USP-1000554 | Acamprosate Calcium | 200 mg |
| USP-1000565 | Acamprosate Related Compound A - (3-aminopropane-1-sulfonic acid) | 15 mg |
| USP-1013545 | Almotriptan Related Compound B - (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate) | 15 mg |
| USP-1013567 | Almotriptan Related Compound D - (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride) | 15 mg |
| USP-1042408 | Argatroban | 350 mg |
| USP-1042419 | Argatroban Related Compound A - ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | 15 mg |
| USP-1044425 | This item has been discontinued - Atenolol Related Compound B - (2-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetonitrile) | 20 mg |
| USP-1044436 | This item has been discontinued - Atenolol Related Compound C - (2-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl} acetic acid) | 20 mg |
| USP-1044447 | This item has been discontinued - Atenolol Related Compound D - (N-Isopropyl-N,N-bis{3-[4-(2-amino-2-oxoethyl)phenoxy]-2-hydroxyprop-1-yl}amine) | 20 mg |
| USP-1044451 | This item has been discontinued - Atenolol Related Compound E - (2-{4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}acetamide) | 20 mg |
| USP-1082956 | Butane-1,3-diol | 1 mL |
| USP-1131960 | Cholesterol | 125 mg |
| USP-1134118 | Cisatracurium Besylate | 350 mg |
| USP-1134131 | Cisatracurium Besylate System Suitability Mixture | 20 mg |